Russian vaccine Sputnik V will not change or adapt the formulation to the Indian coronavirus strain or other new variations, said the head of Gamaleya Center Alexander Gintsburg, according to TASS.
He said that developing a new vaccination is a lengthy procedure.
“The scientific portion will take ten days, and the regulatory procedure will take around three to four months. The virus will evolve during this time, and a new strain will arise. Given the image of the mutation activity of SARS-CoV-2, producing vaccines tailored to new strains is a thankless task. As a result, we’re heading in the opposite direction. With the help of the vaccination that is now available, it is important to maintain high titers,” Gintsburg said.
It is more powerful against the Indian strain than any other vaccination, according to a message posted on the Sputnik V Twitter account on June 15. Gintsburg reported in late April that Sputnik had produced enough antibodies to combat the Indian coronavirus strain.
Anna Popova, the head of Rospotrebnadzor, warned on June 17 that the Indian strain has spread widely throughout the country. On the same day, Russian Prime Minister Mikhail Mishustin stated that it is critical to continue investigating novel coronavirus strains and to take every precaution to avoid their spread.
